Anthony M. Manning

CIK 1716468 · Chief Scientific Officer · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$497.5K

Companies

3

Total Filings

55

Lifetime Open-Market Net

-$6.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GLUE Director 10,000 $22.04 $220.4K -$180.1K 5 2026-06-12
PTN Director 36,080 $7.68 $277.1K $0 9 2024-07-16
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Chief Scientific Officer 0 -$6.34M 39 2020-10-01

Recent Filings · Page 2 of 6

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-06-24 PTN Grant (A) +77,000 $0 EDGAR
2020-10-01 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Disp (D) −12,778 $0 EDGAR
2020-08-13 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −403 -$11.8K EDGAR
2020-08-11 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Mixed +403 -$11.2K EDGAR
2020-07-23 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −1,939 -$67.3K EDGAR
2020-07-21 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Mixed −14,474 -$1.31M EDGAR
2020-07-01 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Mixed +8,189 -$239.1K EDGAR
2020-06-18 PTN Grant (A) +73,000 $0 EDGAR
2020-06-15 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Mixed +8,244 -$203.7K EDGAR
2020-05-12 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −414 -$14.0K EDGAR
Showing 1120 of 55
Page 2 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.